Research Guide
How patents and competition shape drug value
A drug's value depends not only on clinical data, but also on exclusivity, composition-of-matter protection, formulation and method patents, lifecycle strategy, and the competitive products arriving before or after it.
What to check first
Start with the evidence that can change value: clinical relevance, regulatory path, competitive context, financing needs, and whether the company can reach the next milestone.
How Drugnews uses this guide
We apply these frameworks when writing company research, paid analysis, and client-facing content so that readers can follow the logic behind each judgment.